Spinal Cord Injuries

4
Pipeline Programs
13
Companies
19
Clinical Trials
4 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
1
0
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

12 companies ranked by most advanced pipeline stage

N
NeuroplastFrance - Montpellier
2 programs
1
1
Neuro-CellsPhase 2/31 trial
Neuro-CellsPhase 11 trial
Active Trials
NCT04205019Completed10Est. Mar 2023
NCT03935724Unknown16Est. Aug 2024
NervGen Pharma
NervGen PharmaVANCOUVER, British Columbia, Canada
1 program
1
NVG-291Phase 1/21 trial
Active Trials
NCT05965700RecruitingEst. Apr 2026
Boehringer Ingelheim
Boehringer IngelheimINGELHEIM, Germany
1 program
1
KUC 7483 CLPhase 11 trial
Active Trials
NCT02259751Completed26
C
ColoplastAustralia - Mulgrave
5 programs
CystometrogramN/A1 trial
HPC - SpeediCath ®N/A1 trial
SelfCathN/A1 trial
SpeediCathN/A1 trial
test intermittent catheterN/A1 trial
Active Trials
NCT05207826WithdrawnEst. Dec 2023
NCT05003999CompletedEst. Jun 2019
NCT02230540TerminatedEst. Sep 2014
+2 more trials
Cosmo Pharmaceuticals
Cosmo PharmaceuticalsIreland - Dublin
2 programs
ExoAtlet IIN/A1 trial
Gait training using ExoAtlet exoskeletonN/A1 trial
Active Trials
NCT04532723WithdrawnEst. Oct 2023
NCT04215081CompletedEst. Jan 2020
ConvaTec
ConvaTecNJ - Bridgewater
2 programs
GentleCath™ Air catheterN/A1 trial
Self-catheterizationN/A1 trial
Active Trials
NCT04847609WithdrawnEst. Oct 2021
NCT05380661RecruitingEst. Dec 2024
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
ABLE ExoskeletonN/A1 trial
Active Trials
NCT04876794Completed24Est. Nov 2021
Petros Pharmaceuticals
1 program
Cold environment participants with spinal cord injuryN/A1 trial
Active Trials
NCT04215939CompletedEst. Jul 2020
Ekso Bionics
Ekso BionicsSAN RAFAEL, CA
1 program
EksoN/A1 trial
Active Trials
NCT02566850TerminatedEst. Jul 2017
Stoke Therapeutics
1 program
Experimental: Device InterventionN/A1 trial
Active Trials
NCT05615766RecruitingEst. Mar 2026
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Keeping a 1-day food consumption record by the patientN/A1 trial
Active Trials
NCT05997251CompletedEst. Mar 2022
Providence Therapeutics
1 program
Transcutaneous Spinal Cord StimulationN/A1 trial
Active Trials
NCT04604951RecruitingEst. Aug 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NeuroplastNeuro-Cells
NervGen PharmaNVG-291
NeuroplastNeuro-Cells
Boehringer IngelheimKUC 7483 CL
Stoke TherapeuticsExperimental: Device Intervention
ConvaTecSelf-catheterization
Providence TherapeuticsTranscutaneous Spinal Cord Stimulation
ColoplastCystometrogram
Cosmo PharmaceuticalsExoAtlet II
ConvaTecGentleCath™ Air catheter
City TherapeuticsKeeping a 1-day food consumption record by the patient
Heidelberg PharmaABLE Exoskeleton
Cosmo PharmaceuticalsGait training using ExoAtlet exoskeleton
Petros PharmaceuticalsCold environment participants with spinal cord injury
ColoplastHPC - SpeediCath ®

Showing 15 of 19 trials with date data

Clinical Trials (19)

Total enrollment: 76 patients across 19 trials

Stem Cells in Spinal Cord Injury

Start: Jan 2022Est. completion: Aug 202416 patients
Phase 2/3Unknown

NVG-291 in Spinal Cord Injury Subjects

Start: Aug 2023Est. completion: Apr 2026
Phase 1/2Recruiting

Safety Stem Cells in Spinal Cord Injury

Start: Nov 2020Est. completion: Mar 202310 patients
Phase 1Completed

Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity

Start: Feb 200426 patients
Phase 1Completed
NCT05615766Stoke TherapeuticsExperimental: Device Intervention

Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation

Start: Sep 2022Est. completion: Mar 2026
N/ARecruiting
NCT05380661ConvaTecSelf-catheterization

Heart Rate Variability and Anxiety During Urinary Bladder Catheterization

Start: Jul 2022Est. completion: Dec 2024
N/ARecruiting
NCT04604951Providence TherapeuticsTranscutaneous Spinal Cord Stimulation

Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury

Start: May 2022Est. completion: Aug 2024
N/ARecruiting
NCT05207826ColoplastCystometrogram

Detrusor Activity Recovery in Acute Traumatic Spinal Cord Injuries

Start: Mar 2022Est. completion: Dec 2023
N/AWithdrawn

Exoskeleton-Assisted Walking ExoAtlet II

Start: Jun 2021Est. completion: Oct 2023
N/AWithdrawn
NCT04847609ConvaTecGentleCath™ Air catheter

GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders

Start: May 2021Est. completion: Oct 2021
N/AWithdrawn
NCT05997251City TherapeuticsKeeping a 1-day food consumption record by the patient

The Relationship of DASH and Mediterranean Diet Score With Serum Adiponectin Levels in Patients With Spinal Cord Injury

Start: Mar 2021Est. completion: Mar 2022
N/ACompleted

Clinical Investigation on Safety, Feasibility and Usability of the ABLE Exoskeleton Device With Spinal Cord Injured Patients in a Hospital Setting

Start: Nov 2020Est. completion: Nov 202124 patients
N/ACompleted
NCT04215081Cosmo PharmaceuticalsGait training using ExoAtlet exoskeleton

ExoAtlet II For SCI Patients

Start: Nov 2019Est. completion: Jan 2020
N/ACompleted
NCT04215939Petros PharmaceuticalsCold environment participants with spinal cord injury

Assessment of Vasomotion of People With Spinal Cord Injury

Start: Feb 2019Est. completion: Jul 2020
N/ACompleted
NCT05003999ColoplastHPC - SpeediCath ®

Time Needed to Perform Intermittent Catheterization in Adults With Spinal Cord Injuries

Start: Dec 2018Est. completion: Jun 2019
N/ACompleted

Exploratory Study Investigating Urodynamic Parameters During Catheterisation

Start: Nov 2017Est. completion: May 2018
N/ACompleted

Intermittent Catheterization in Spinal Cord Injured Men

Start: Sep 2014Est. completion: Sep 2014
N/ATerminated

Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment

Start: Jan 2014Est. completion: Jul 2017
N/ATerminated
NCT00990093Coloplasttest intermittent catheter

A Randomised, Cross-over, Open-labelled Test Catheter Acceptance Study

Start: Nov 2009Est. completion: Mar 2010
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 actively recruiting trials targeting 76 patients
13 companies competing in this space